EU Congestive Heart Failure Market, Market Segmented by Drugs Class (Beta Blockers, ACE Inhibitors, Angiotensin Receptor Bockers, Diuretics, Inotropic Agents, Aldosterone Antagonist, Calcium Channel Blockers, and Others), by Route Of Administration (Oral and Intravenous), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138283
- Pages: 200
-
Format:
Report Overview
The EU Congestive Heart Failure Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Market Drivers and Restraints
Increase in prevalence of cardiovascular diseases is one the major factors expected to drive the growth of congestive heart failure treatment. Lifestyle related factors are expected to add to growing disease incidence of CVDs
The availability of the generic drugs and lack of end stage pipeline drugs and therapies for congestive heart failure treatment is about to hinder the market
1. EU Congestive Heart Failure Market Overview
A. Market Size
2. EU Congestive Heart Failure Market Growth Drivers and Restraints
A. Increase in prevalence of cardiovascular diseases
B. Lifestyle related factors
C. The availability of the generic drugs and lack of end stage pipeline drugs and therapies for congestive heart failure treatment
3. EU Congestive Heart Failure Market Segmentation
A. By Drug Class
I. Beta Blockers
II. ACE Inhibitors
III. Angiotensin Receptor Blockers
IV. Diuretics
V. Inotropic Agents
VI. Aldosterone Antagonist
VII. Calcium Channel Blockers
VIII. Others
B. By Route of Administration
I. Oral
II. Intravenous
C. By Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
4. EU Congestive Heart Failure Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Astra Zeneca, Company overview, Product & Services, Strategies & Financials
B. Bristol-Myers Squibb Philips N.V., Company overview, Product & Services, Strategies & Financials
C. Merck & Co Inc, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
